These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29740969)

  • 1. Peripheral cannabinoid 1 receptor blockade mitigates adipose tissue inflammation via NLRP3 inflammasome in mouse models of obesity.
    Han JH; Shin H; Rho JG; Kim JE; Son DH; Yoon J; Lee YJ; Park JH; Song BJ; Choi CS; Yoon SG; Kim IY; Lee EK; Seong JK; Kim KW; Kim W
    Diabetes Obes Metab; 2018 Sep; 20(9):2179-2189. PubMed ID: 29740969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.
    Han JH; Shin H; Park JY; Rho JG; Son DH; Kim KW; Seong JK; Yoon SH; Kim W
    FASEB J; 2019 Mar; 33(3):4314-4326. PubMed ID: 30566396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-Deoxygarcinol improves insulin sensitivity in high-fat diet-induced obese mice via mitigating NF-κB/Sirtuin 2-NLRP3-mediated adipose tissue remodeling.
    Chen JL; Feng ZL; Zhou F; Lou RH; Peng C; Ye Y; Lin LG
    Acta Pharmacol Sin; 2023 Feb; 44(2):434-445. PubMed ID: 35945312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.
    Camell CD; Nguyen KY; Jurczak MJ; Christian BE; Shulman GI; Shadel GS; Dixit VD
    J Biol Chem; 2015 Dec; 290(49):29402-13. PubMed ID: 26438821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling.
    Healy NP; Kirwan AM; McArdle MA; Holohan K; Nongonierma AB; Keane D; Kelly S; Celkova L; Lyons CL; McGillicuddy FC; Finucane OM; Murray BA; Kelly PM; Brennan L; FitzGerald RJ; Roche HM
    Mol Nutr Food Res; 2016 Nov; 60(11):2421-2432. PubMed ID: 27390025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NLRP3 inflammasome regulates adipose tissue metabolism.
    Barra NG; Henriksbo BD; Anhê FF; Schertzer JD
    Biochem J; 2020 Mar; 477(6):1089-1107. PubMed ID: 32202638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of Adipose Tissue Inflammation in Obesity.
    Engin A
    Adv Exp Med Biol; 2024; 1460():297-327. PubMed ID: 39287856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity.
    Mehrpouya-Bahrami P; Chitrala KN; Ganewatta MS; Tang C; Murphy EA; Enos RT; Velazquez KT; McCellan J; Nagarkatti M; Nagarkatti P
    Sci Rep; 2017 Nov; 7(1):15645. PubMed ID: 29142285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chikusetsu saponin IVa ameliorates high fat diet-induced inflammation in adipose tissue of mice through inhibition of NLRP3 inflammasome activation and NF-κB signaling.
    Yuan C; Liu C; Wang T; He Y; Zhou Z; Dun Y; Zhao H; Ren D; Wang J; Zhang C; Yuan D
    Oncotarget; 2017 May; 8(19):31023-31040. PubMed ID: 28415686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.
    Wada T; Ishikawa A; Watanabe E; Nakamura Y; Aruga Y; Hasegawa H; Onogi Y; Honda H; Nagai Y; Takatsu K; Ishii Y; Sasahara M; Koya D; Tsuneki H; Sasaoka T
    J Endocrinol; 2017 Dec; 235(3):179-191. PubMed ID: 28855315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 Inflammasome Activation in Adipose Tissues and Its Implications on Metabolic Diseases.
    Wu KK; Cheung SW; Cheng KK
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice.
    Li A; Zhang S; Li J; Liu K; Huang F; Liu B
    Mol Cell Endocrinol; 2016 Oct; 434():36-47. PubMed ID: 27276511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights Into the Interplay Among Autophagy, the NLRP3 Inflammasome and Inflammation in Adipose Tissue.
    Zhu L; Liu L
    Front Endocrinol (Lausanne); 2022; 13():739882. PubMed ID: 35432210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance.
    Henriksbo BD; Lau TC; Cavallari JF; Denou E; Chi W; Lally JS; Crane JD; Duggan BM; Foley KP; Fullerton MD; Tarnopolsky MA; Steinberg GR; Schertzer JD
    Diabetes; 2014 Nov; 63(11):3742-7. PubMed ID: 24917577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.
    Vandanmagsar B; Youm YH; Ravussin A; Galgani JE; Stadler K; Mynatt RL; Ravussin E; Stephens JM; Dixit VD
    Nat Med; 2011 Feb; 17(2):179-88. PubMed ID: 21217695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation.
    Demidowich AP; Davis AI; Dedhia N; Yanovski JA
    Med Hypotheses; 2016 Jul; 92():67-73. PubMed ID: 27241260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage Polarization Mediated by Mitochondrial Dysfunction Induces Adipose Tissue Inflammation in Obesity.
    Xu L; Yan X; Zhao Y; Wang J; Liu B; Yu S; Fu J; Liu Y; Su J
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement.
    Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q
    Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation.
    ZhuGe DL; Javaid HMA; Sahar NE; Zhao YZ; Huh JY
    Arch Pharm Res; 2020 Dec; 43(12):1311-1324. PubMed ID: 33245516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.